Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 25871392)

  • 1. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
    Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
    Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion.
    Wang F; Yang L; Gao Q; Huang L; Wang L; Wang J; Wang S; Zhang B; Zhang Y
    Cancer Immunol Immunother; 2015 Aug; 64(8):965-76. PubMed ID: 25944005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages.
    Li L; Yang L; Wang L; Wang F; Zhang Z; Li J; Yue D; Chen X; Ping Y; Huang L; Zhang B; Zhang Y
    Int J Cancer; 2016 Nov; 139(10):2261-9. PubMed ID: 27459735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis.
    Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X
    Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.
    Wu MF; Lin CA; Yuan TH; Yeh HY; Su SF; Guo CL; Chang GC; Li KC; Ho CC; Chen HW
    Cancer Immunol Immunother; 2021 May; 70(5):1435-1450. PubMed ID: 33175182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel biomarker of alternative macrophage activation, soluble mannose receptor (sMR/sCD206): Implications in multiple myeloma.
    Andersen MN; Andersen NF; Rødgaard-Hansen S; Hokland M; Abildgaard N; Møller HJ
    Leuk Res; 2015 Sep; 39(9):971-5. PubMed ID: 26169445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.
    Gao J; Song L; Li D; Peng L; Ding H
    Medicine (Baltimore); 2019 Oct; 98(42):e17416. PubMed ID: 31626097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma.
    Kim KJ; Wen XY; Yang HK; Kim WH; Kang GH
    PLoS One; 2015; 10(12):e0144192. PubMed ID: 26714314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
    Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y
    Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese medicine Xiaoshui decoction inhibits malignant pleural effusion in mice and mediates tumor-associated macrophage polarization by activating autophagy.
    Jin Z; Shen C; Zhang H; Qi R; Guo Q; Liu R; Hua B; Shi Z
    J Ethnopharmacol; 2020 Mar; 249():112412. PubMed ID: 31751649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma.
    Komohara Y; Niino D; Saito Y; Ohnishi K; Horlad H; Ohshima K; Takeya M
    Cancer Sci; 2013 Jul; 104(7):945-51. PubMed ID: 23557330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy.
    Di Caro G; Cortese N; Castino GF; Grizzi F; Gavazzi F; Ridolfi C; Capretti G; Mineri R; Todoric J; Zerbi A; Allavena P; Mantovani A; Marchesi F
    Gut; 2016 Oct; 65(10):1710-20. PubMed ID: 26156960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD163 as a Biomarker in Colorectal Cancer: The Expression on Circulating Monocytes and Tumor-Associated Macrophages, and the Soluble Form in the Blood.
    Krijgsman D; De Vries NL; Andersen MN; Skovbo A; Tollenaar RAEM; Møller HJ; Hokland M; Kuppen PJK
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer.
    Park JY; Sung JY; Lee J; Park YK; Kim YW; Kim GY; Won KY; Lim SJ
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):357-365. PubMed ID: 26508473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast.
    Jamiyan T; Kuroda H; Yamaguchi R; Abe A; Hayashi M
    Virchows Arch; 2020 Dec; 477(6):767-775. PubMed ID: 32607685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody combinations for optimized staining of macrophages in human lung tumours.
    Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer.
    Edin S; Wikberg ML; Dahlin AM; Rutegård J; Öberg Å; Oldenborg PA; Palmqvist R
    PLoS One; 2012; 7(10):e47045. PubMed ID: 23077543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse.
    Reinartz S; Schumann T; Finkernagel F; Wortmann A; Jansen JM; Meissner W; Krause M; Schwörer AM; Wagner U; Müller-Brüsselbach S; Müller R
    Int J Cancer; 2014 Jan; 134(1):32-42. PubMed ID: 23784932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of CD68
    Troiano G; Caponio VCA; Adipietro I; Tepedino M; Santoro R; Laino L; Lo Russo L; Cirillo N; Lo Muzio L
    Oral Oncol; 2019 Jun; 93():66-75. PubMed ID: 31109698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.